Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Remitz

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Dermatology|September 12, 2021
Atopic dermatitis in adults: a population-based study in FinlandVille Kiiski, Alexander Salava, Päivikki Susitaival, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2023
A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic DermatitisJoseph Pena, Priscila Arellano Zameza, Jessica N Pixley, et al.
European Journal of Dermatology : EJD|December 22, 2021
Effective treatment of atopic dermatitis in small children significantly improves the quality of life of patients and their familiesAlexander Salava, Miia Perälä, Mona Juppo, et al.
Clinical and Experimental Dermatology|March 14, 2023
Topical tacrolimus versus corticosteroids in childhood moderate-to-severe atopic dermatitis and the impact on airway inflammation: a long-term randomized open-label studyMiia Perälä, Alexander Salava, Pekka Malmberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 5, 2019
Young children with moderate-to-severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroidsMiia Perälä, Maria Ahola, Tytti Mikkola, et al.
Metabolism: Clinical and Experimental|May 22, 2007
13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentrationMaikki K Heliövaara, Anita Remitz, Sakari Reitamo, et al.
The Journal of Dermatological Treatment|April 17, 2010
A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 yearsJohanna M Mandelin, Anita Remitz, Hannele M Virtanen, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 3, 2023
Relevance of Coding Variation in <i>FLG</i> And <i>DOCK8</i> in Finnish Pediatric Patients with Early-Onset Moderate-To-Severe Atopic DermatitisMiia Perälä, Meri Kaustio, Alexander Salava, et al.
International Journal of Dermatology|April 2, 2009
The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitisSakari Reitamo, Johanna Mandelin, Andris Rubins, et al.
International Journal of Dermatology|September 20, 2011
Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label studyJohanna M Mandelin, Andris Rubins, Anita Remitz, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Dermatology|September 12, 2021
Atopic dermatitis in adults: a population-based study in FinlandVille Kiiski, Alexander Salava, Päivikki Susitaival, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2023
A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic DermatitisJoseph Pena, Priscila Arellano Zameza, Jessica N Pixley, et al.
European Journal of Dermatology : EJD|December 22, 2021
Effective treatment of atopic dermatitis in small children significantly improves the quality of life of patients and their familiesAlexander Salava, Miia Perälä, Mona Juppo, et al.
Clinical and Experimental Dermatology|March 14, 2023
Topical tacrolimus versus corticosteroids in childhood moderate-to-severe atopic dermatitis and the impact on airway inflammation: a long-term randomized open-label studyMiia Perälä, Alexander Salava, Pekka Malmberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 5, 2019
Young children with moderate-to-severe atopic dermatitis can be treated safely and effectively with either topical tacrolimus or mild corticosteroidsMiia Perälä, Maria Ahola, Tytti Mikkola, et al.
Metabolism: Clinical and Experimental|May 22, 2007
13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentrationMaikki K Heliövaara, Anita Remitz, Sakari Reitamo, et al.
The Journal of Dermatological Treatment|April 17, 2010
A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 yearsJohanna M Mandelin, Anita Remitz, Hannele M Virtanen, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 3, 2023
Relevance of Coding Variation in <i>FLG</i> And <i>DOCK8</i> in Finnish Pediatric Patients with Early-Onset Moderate-To-Severe Atopic DermatitisMiia Perälä, Meri Kaustio, Alexander Salava, et al.
International Journal of Dermatology|April 2, 2009
The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitisSakari Reitamo, Johanna Mandelin, Andris Rubins, et al.
International Journal of Dermatology|September 20, 2011
Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label studyJohanna M Mandelin, Andris Rubins, Anita Remitz, et al.
Pageof 3